Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.
Haffty BG, Harrold E, Khan AJ, Pathare P, Smith TE, Turner BC, Glazer PM, Ward B, Carter D, Matloff E, Bale AE, Alvarez-Franco M.
Haffty BG, et al. Among authors: carter d.
Lancet. 2002 Apr 27;359(9316):1471-7. doi: 10.1016/S0140-6736(02)08434-9.
Lancet. 2002.
PMID: 11988246